|
12th International Workshop on KSHV and Related Agents
|
1R13CA139817-01
|
$18,000
|
$18,000
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$327,420
|
$163,710
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S1
|
$114,606
|
$2,281
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S3
|
$100,000
|
$1,990
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-34
|
$7,326,647
|
$145,800
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center
|
5U01CA096230-07
|
$739,770
|
$458,657
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
AIDS Malignancy Clinical Trials Consortium
|
3U01CA121947-03S4
|
$3,605,692
|
$2,235,529
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anatomic Pathology Residency Program
|
ZIE BC 010684
|
$1,339,887
|
$66,994
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Anti-viral IL6 approach to mitigate KSHV-related disease
|
5R01CA132638-02
|
$680,879
|
$680,879
|
WONG, SCOTT
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Antigens of Kaposi's sarcoma associated herpesvirus
|
5R01CA075911-13
|
$310,171
|
$310,171
|
Chandran, Bala
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa
|
5R01CA119903-05
|
$355,719
|
$355,719
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Bim regulation by HHV-8 vIRF-1
|
5R21CA136356-02
|
$221,400
|
$221,400
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Biochemical Aspects of Chemotherapy
|
5T32CA009085-35
|
$352,079
|
$88,020
|
CHENG, YUNG-CHI
|
YALE UNIVERSITY
|
|
Cancer Center Core Support Grant
|
3P30CA016086-34S1
|
$253,376
|
$12,669
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-34S2
|
$90,929
|
$4,546
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-34
|
$6,437,293
|
$321,865
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support
|
3P30CA047904-21S2
|
$5,021,590
|
$100,432
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA044579-19S1
|
$98,594
|
$30,564
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Cancer Center Support Grant
|
3P30CA044579-19S2
|
$99,998
|
$30,999
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Cancer Center Support Grant
|
5P30CA044579-19
|
$2,410,577
|
$747,279
|
WEBER, MICHAEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150-10362
|
$355,414
|
$35,541
|
Engels
|
DCEG (NCI)
|
|
Cancer Therapy & Research Center at UTHSCSA
|
2P30CA054174-17
|
$1,368,979
|
$82,139
|
Thompson, Ian
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Cancer Therapy & Research Center at UTHSCSA
|
3P30CA054174-17S1
|
$126,750
|
$7,605
|
Thompson, Ian
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents
|
ZIA BC 006174
|
$126,285
|
$18,943
|
Marquez, Victor
|
CCR (NCI)
|
|
CCR VB FACS CORE
|
ZIC BC 010936
|
$1,006,888
|
$251,722
|
McKinnon, Katherine
|
CCR (NCI)
|
|
Chromatin Dynamics of KSHV Latency
|
5R01CA117830-04
|
$286,431
|
$286,431
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Cis and Trans acting factors for HHV8 lytic replication
|
5R01CA115279-05
|
$271,536
|
$271,536
|
PARI, GREGORY
|
UNIVERSITY OF NEVADA RENO
|
|
Classical KS case-control studies
|
ZIA CP010176-10077
|
$124,626
|
$124,626
|
Goedert
|
DCEG (NCI)
|
|
Clinical trials of patients with AIDS-related malignancies
|
ZIA BC 010888
|
$760,989
|
$380,495
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-40
|
$2,527,733
|
$75,832
|
KAUFMAN, RUSSEL
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-40S2
|
$98,063
|
$2,942
|
KAUFMAN, RUSSEL
|
WISTAR INSTITUTE
|
|
CYTOTOXIC T CELL RESPONSES TO HHV-8
|
2R01CA082053-09A2
|
$372,355
|
$279,266
|
RINALDO, CHARLES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$300,758
|
$255,644
|
Burke, Terrence
|
CCR (NCI)
|
|
Design of Antiviral Drugs Effective Against the HIV-1 Virus
|
ZIA BC 009101
|
$154,557
|
$77,278
|
Appella, Ettore
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Cellular Immunity
|
ZIA BC 011062
|
$1,314,746
|
$657,373
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Humoral Immunity
|
ZIA BC 011058
|
$1,314,746
|
$657,373
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Translation to the Clinic
|
ZIA BC 011063
|
$292,166
|
$146,083
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$422,772
|
$126,832
|
Yarchoan, Robert
|
CCR (NCI)
|
|
DNA Vaccines
|
ZIA BC 010749
|
$867,130
|
$867,130
|
Pavlakis, George
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$875,336
|
$87,534
|
Carrington, Mary
|
CCR (NCI)
|
|
Enhanced Cell-mediated Immunogenicity of KSHV LANA1 Protein
|
5R01CA121930-04
|
$255,442
|
$255,442
|
MOORE, PATRICK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Functions of KSHV microRNAs
|
ZIA BC 011176
|
$618,420
|
$618,420
|
Ziegelbauer, Joseph
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$857,614
|
$171,523
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$956,040
|
$95,604
|
Gottesman, Michael
|
CCR (NCI)
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
3R01CA082036-10S1
|
$69,244
|
$69,244
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-10
|
$421,279
|
$421,279
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Herpresviral Gene Expression in Kaposis Sarcoma
|
5R01CA073506-13
|
$270,375
|
$270,375
|
GANEM, DON
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
HIV AIDS cancer match, U.S.
|
ZIA CP010176-10071
|
$441,575
|
$132,473
|
Engels
|
DCEG (NCI)
|
|
HIV Integrase Modeling and Computer-Aided Inhibitor Development
|
ZIA BC 010524
|
$156,919
|
$156,919
|
Nicklaus, Marc
|
CCR (NCI)
|
|
HIV Tat Transcriptional Activation
|
ZIA BC 005753
|
$261,401
|
$52,280
|
Brady, John
|
CCR (NCI)
|
Total relevant funding to Kaposi Sarcoma for this search: $25,155,209
|